DKK648.00
0.22% today
Copenhagen, May 21, 04:59 pm CET
ISIN
DK0060448595
Symbol
COLO B
Sector

Coloplast A/S B Target price 2025 - Analyst rating & recommendation

Coloplast A/S B Classifications & Recommendation:

Buy
24%
Hold
68%
Sell
8%

Coloplast A/S B Price Target

Target Price DKK750.46
Price DKK648.00
Potential
Number of Estimates 22
22 Analysts have issued a price target Coloplast A/S B 2026 . The average Coloplast A/S B target price is DKK750.46. This is higher than the current stock price. The highest price target is
DKK950.00 46.60%
register free of charge
, the lowest is .
A rating was issued by 25 analysts: 6 Analysts recommend Coloplast A/S B to buy, 17 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Coloplast A/S B stock has an average upside potential 2026 of . Most analysts recommend the Coloplast A/S B stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Revenue Billion DKK 27.03 28.34
10.33% 4.84%
EBITDA Margin 29.86% 31.97%
2.45% 0.67%

22 Analysts have issued a sales forecast Coloplast A/S B 2025 . The average Coloplast A/S B sales estimate is

DKK28.3b
Unlock
. This is
1.96% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
DKK28.9b 4.02%
Unlock
, the lowest is
DKK27.9b 0.49%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 DKK27.0b 10.33%
2025
DKK28.3b 4.84%
Unlock
2026
DKK30.5b 7.70%
Unlock
2027
DKK33.1b 8.34%
Unlock
2028
DKK36.3b 9.75%
Unlock
2029
DKK39.3b 8.29%
Unlock

22 Analysts have issued an Coloplast A/S B EBITDA forecast 2025. The average Coloplast A/S B EBITDA estimate is

DKK9.1b
Unlock
. This is
1.46% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
DKK9.4b 6.67%
Unlock
, the lowest is
DKK8.5b 3.84%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 DKK8.1b 7.63%
2025
DKK9.1b 4.14%
Unlock
2026
DKK10.0b 10.41%
Unlock
2027
DKK11.0b 10.32%
Unlock
2028
DKK12.6b 14.20%
Unlock
2029
DKK13.9b 9.90%
Unlock

EBITDA Margin

2024 29.86% 2.45%
2025
31.97% 0.67%
Unlock
2026
32.78% 2.53%
Unlock
2027
33.37% 1.80%
Unlock
2028
34.73% 4.08%
Unlock
2029
35.25% 1.50%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Earnings Per Share DKK 22.46 18.32
1.22% 18.43%
P/E 35.45
EV/Sales 6.00

19 Analysts have issued a Coloplast A/S B forecast for earnings per share. The average Coloplast A/S B EPS is

DKK18.32
Unlock
. This is
9.26% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
DKK23.81 18.05%
Unlock
, the lowest is
DKK16.41 18.64%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 DKK22.46 1.22%
2025
DKK18.32 18.43%
Unlock
2026
DKK27.15 48.20%
Unlock
2027
DKK30.62 12.78%
Unlock
2028
DKK36.33 18.65%
Unlock
2029
DKK40.76 12.19%
Unlock

P/E ratio

Current 32.17 16.40%
2025
35.45 10.20%
Unlock
2026
23.92 32.52%
Unlock
2027
21.21 11.33%
Unlock
2028
17.87 15.75%
Unlock
2029
15.93 10.86%
Unlock

Based on analysts' sales estimates for 2025, the Coloplast A/S B stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.11 27.43%
2025
6.00 1.88%
Unlock
2026
5.57 7.15%
Unlock
2027
5.14 7.70%
Unlock
2028
4.68 8.88%
Unlock
2029
4.32 7.66%
Unlock

P/S ratio

Current 5.27 29.73%
2025
5.16 1.92%
Unlock
2026
4.80 7.15%
Unlock
2027
4.43 7.70%
Unlock
2028
4.03 8.88%
Unlock
2029
3.72 7.65%
Unlock

Current Coloplast A/S B Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Mar 31 2025
JEFFERIES
Locked
Locked
Locked Mar 31 2025
HSBC
Locked
Locked
Locked Mar 23 2025
REDBURN ATLANTIC
Locked
Locked
Locked Mar 20 2025
EQUITA SIM
Locked
Locked
Locked Feb 06 2025
DNB MARKETS
Locked
Locked
Locked Feb 04 2025
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Feb 04 2025
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Mar 31 2025
Locked
JEFFERIES:
Locked
Locked
Mar 31 2025
Locked
HSBC:
Locked
Locked
Mar 23 2025
Locked
REDBURN ATLANTIC:
Locked
Locked
Mar 20 2025
Locked
EQUITA SIM:
Locked
Locked
Feb 06 2025
Locked
DNB MARKETS:
Locked
Locked
Feb 04 2025
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Feb 04 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today